Core Viewpoint - Nutriband has selected a commercial worldwide brand name for its lead product, an abuse deterrent fentanyl transdermal system, and will submit it to the FDA for approval [1][3] Group 1: Product Development - Nutriband's lead product utilizes AVERSA™ abuse deterrent technology, which aims to prevent the abuse and misuse of transdermal fentanyl [2][7] - The product has the potential to achieve peak annual US sales between $80 million to $200 million, with plans for development in major medical markets worldwide [3][9] Group 2: Branding and Regulatory Support - The company has partnered with Brand Institute, Inc. to develop the brand name and visual identity for the product, leveraging their expertise in pharmaceutical branding [2][5] - Drug Safety Institute, a subsidiary of Brand Institute, will provide regulatory services and support, staffed by former officials from major health agencies [6][11] Group 3: Intellectual Property - Nutriband's AVERSA™ technology is protected by a broad international intellectual property portfolio, with patents issued in 46 countries [7][8]

Core Insights - Nutriband Inc. has signed an Associate Partnership agreement with Charlotte FC to enhance brand visibility, particularly for its AI Tape product manufactured locally in Charlotte [1][2] - The partnership aims to promote Nutriband's AVERSA platform technology, which is positioned as a potential first-of-its-kind abuse deterrent patch for chronic pain management [3] - Nutriband is focused on developing a portfolio of transdermal pharmaceutical products, with its lead product being an abuse deterrent fentanyl patch utilizing AVERSA technology [4] Company Overview - Nutriband Inc. specializes in transdermal pharmaceutical products, with a manufacturing facility located in North Carolina [2][4] - The AVERSA technology is designed to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential, and can be integrated into any transdermal patch [4]

As filed with the Securities and Exchange Commission on May 10, 2023 Registration No. 333-_____ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Nutriband Inc. (Exact name of registrant as specified in its charter) (State or jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Nevada 2834 81-1118176 (I.R.S. Employer Identification No.) 121 South Orange Ave., Suite 1500 O ...